data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Genfit
(NASDAQ:GNFT)
3.28
-0.08[-2.38%]
At close: Jun 24
3.33
0.0500[1.52%]
After Hours: 4:05AM EDT
Day High/Low3.29 - 3.39
52 Week High/Low3.01 - 6.38
Open / Close3.39 / 3.38
Float / Outstanding- / 49.8M
Vol / Avg.2.2K / 14.9K
Mkt Cap163.4M
P/E2.6
50d Avg. Price3.56
Div / Yield-
Payout Ratio-
EPS-
Total Float48.2M

Genfit (NASDAQ:GNFT), Quotes and News Summary

Genfit (NASDAQ: GNFT)

Day High/Low3.29 - 3.39
52 Week High/Low3.01 - 6.38
Open / Close3.39 / 3.38
Float / Outstanding- / 49.8M
Vol / Avg.2.2K / 14.9K
Mkt Cap163.4M
P/E2.6
50d Avg. Price3.56
Div / Yield-
Payout Ratio-
EPS-
Total Float48.2M
Benzinga - Jun 7, 2022, 12:01PM
Benzinga - Apr 11, 2022, 4:42AM
Benzinga - Apr 7, 2022, 4:12PM
Benzinga - Dec 20, 2021, 6:30AM
Benzinga - Dec 17, 2021, 10:57AM
Benzinga - Dec 17, 2021, 8:29AM
Benzinga - Dec 17, 2021, 6:25AM
Benzinga - Dec 17, 2021, 5:36AM
load more
Sector: Health Care.Industry: Biotechnology
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development.
Read More

Earnings

see more
H1 2022Est.ActualSurprise
EPS
(EXPECTED)2022-09-12
REV
FY 2021Est.ActualSurprise
EPS1.460
REV101.271M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Genfit Questions & Answers

Q
How do I buy Genfit (GNFT) stock?
A

You can purchase shares of Genfit (NASDAQ: GNFT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Genfit's (GNFT) competitors?
Q
What is the target price for Genfit (GNFT) stock?
A

The latest price target for Genfit (NASDAQ: GNFT) was reported by SVB Leerink on Monday, April 11, 2022. The analyst firm set a price target for 10.00 expecting GNFT to rise to within 12 months (a possible 204.88% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Genfit (GNFT)?
A

The stock price for Genfit (NASDAQ: GNFT) is $3.28 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Genfit (GNFT) pay a dividend?
A

There are no upcoming dividends for Genfit.

Q
When is Genfit (NASDAQ:GNFT) reporting earnings?
A

Genfit’s H1 earnings are confirmed for Monday, September 12, 2022.

Q
Is Genfit (GNFT) going to split?
A

There is no upcoming split for Genfit.

Q
What sector and industry does Genfit (GNFT) operate in?
A

Genfit is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.